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Artemisinin is the basis for the method of choice in the treatment of resistant malaria. In 
addition to this, artemisinin is also active against cancer, hepatitis and schistosomiasis [1]. 
The increasing demand for artemisinin has led to shortages. Because chemical synthesis of 
artemisinin is impossible for a reasonable price, Artemisia annua is the only commercial 
source. Unfortunately, this plant produces small amounts of artemisinin. Therefore, attempts 
were made for engineering heterologous plants and microbes to produce artemisinin, but only 
the production of artemisinin precursors was achieved [2]. This is due to an incomplete 
knowledge of the biosynthetic pathway of artemisinin. Artemisinin is produced in specialized 
10-celled glandular trichomes on the leaves, stems and inflorescences. Transcripts for 
enzymes involved in the artemisinin synthesis, were detected exclusively in the apical 
trichome cells [3]. This suggests that only apical cells are producing artemisinin.  
 
By comparing transcripts of apical and sub-apical cells, there is a possibility to discover new 
genes that are involved in the biosynthesis of artemisinin. Therefore, the whole  transcriptome 
of apical and sub-apical cells will be analyzed with next-generation sequencing.  
 
Apical and sub-apical cells of the trichomes were isolated with laser microdissection and 
pressure catapulting (LMPC). Thereafter, a procedure was optimized for linear amplification 
of  mRNA to prepare the samples for next-generation-sequencing. Sequencing will be 
performed with the Illumina Genome Analyzer II platform. 
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